<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03198611</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-REP-2017-30</org_study_id>
    <nct_id>NCT03198611</nct_id>
  </id_info>
  <brief_title>Reversibility of Diastolic Disfunction in Septic Shock</brief_title>
  <acronym>REPRISS</acronym>
  <official_title>Early Reversibility of Diastolic Disfunction as a Prognostic Factor in Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spanish Clinical Research Network - CAIBER</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives: To study the prognostic value of the evolution of diastolic function according to
      fluid balance in patients admitted to the ICU with a diagnosis of septic shock, in terms of
      mortality (ICU and hospital) and mortality at 90 days.

      2.4. Secondary objectives: A) Incidence and reversibility of myocardial dysfunction (left
      ventricular systolic and diastolic) in septic shock.

      B) Incidence and reversibility of diastolic dysfunction according to the echocardiographic
      criterion used.

      C) Incidence and reversibility of right ventricular systolic dysfunction.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality at 90 days</measure>
    <time_frame>90 days</time_frame>
    <description>Dead at 90 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Dead in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In hospital mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Dead in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of myocardial disfunction</measure>
    <time_frame>During the first 24 hours of ICU admission</time_frame>
    <description>According to the criteria specified at groups section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in incidence of diastolic dysfunction</measure>
    <time_frame>From first 24 hours of ICU admission until 48h, 72h and 7 days from admission</time_frame>
    <description>Change in incidence of diastolic dysfunction according to the different criteria used.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Diastolic Dysfunction</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Normal function</arm_group_label>
    <description>No systolic dysfunction No diastolic dysfunction No right ventricular dysfunction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left ventricular systolic dysfunction</arm_group_label>
    <description>Left ventricular ejection fraction &lt; 50%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left ventricular diastolic dysfunction</arm_group_label>
    <description>Classification according to:
Mitral lateral annulus e' in tissue Doppler &lt; 10 cm/s
American society of echocardiography (ASE) criteria 2009
ASE criteria 2016</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right ventricular dysfunction</arm_group_label>
    <description>Tricuspid annulus plane systolic excursion &lt; 17 cm</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <description>Usual echocardiographic studies in patients suffering septic shock</description>
    <arm_group_label>Normal function</arm_group_label>
    <arm_group_label>Left ventricular systolic dysfunction</arm_group_label>
    <arm_group_label>Left ventricular diastolic dysfunction</arm_group_label>
    <arm_group_label>Right ventricular dysfunction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to the ICU with diagnosis of septic shock, and stay longer than 48h
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to the ICU with diagnosis of septic shock, and stay longer than 48h

        Exclusion Criteria:

          -  No echocardiographic window

          -  Fatal prognosis with do not resuscitate orders at admission

          -  Previous history of Ischemic cardiomyopathy

          -  Valvular prosthesis

          -  Advanced degree of valvular disorder

          -  Advanced degree of pericardial effusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luis Zapata Fenor, MD PhD</last_name>
    <phone>0034935537255</phone>
    <email>LZapata@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Verge de la Cinta</name>
      <address>
        <city>Tortosa</city>
        <state>Tarragona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferran Roche-Campo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis Zapata Fenor, MD PhD</last_name>
      <phone>0034935537255</phone>
      <email>LZapata@santpau.cat</email>
    </contact>
    <investigator>
      <last_name>Luis Zapata Fenor, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lluis Zapata, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Purificacion Perez</last_name>
    </contact>
    <investigator>
      <last_name>Irene Dot</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Vall d´Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Garcia</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Suárez JC, López P, Mancebo J, Zapata L. Diastolic dysfunction in the critically ill patient. Response from the authors. Med Intensiva. 2017 Apr;41(3):198. doi: 10.1016/j.medin.2016.12.008. Epub 2017 Mar 3. English, Spanish.</citation>
    <PMID>28262372</PMID>
  </reference>
  <reference>
    <citation>Mahjoub Y, Benoit-Fallet H, Airapetian N, Lorne E, Levrard M, Seydi AA, Amennouche N, Slama M, Dupont H. Improvement of left ventricular relaxation as assessed by tissue Doppler imaging in fluid-responsive critically ill septic patients. Intensive Care Med. 2012 Sep;38(9):1461-70. doi: 10.1007/s00134-012-2618-9. Epub 2012 Jun 21.</citation>
    <PMID>22717694</PMID>
  </reference>
  <reference>
    <citation>Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Alexandru Popescu B, Waggoner AD; Houston, Texas; Oslo, Norway; Phoenix, Arizona; Nashville, Tennessee; Hamilton, Ontario, Canada; Uppsala, Sweden; Ghent and Liège, Belgium; Cleveland, Ohio; Novara, Italy; Rochester, Minnesota; Bucharest, Romania; and St. Louis, Missouri. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360. Epub 2016 Jul 15. Review.</citation>
    <PMID>27422899</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2017</study_first_submitted>
  <study_first_submitted_qc>June 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2017</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

